221
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium

ORCID Icon
Pages 77-89 | Received 29 Aug 2023, Accepted 07 Nov 2023, Published online: 19 Nov 2023

Figures & data

Table 1 Baseline Demographic and Clinical Parameters (N = 50)

Figure 1 Change in hair growth indicators, by scalp region, in patients with telogen effluvium after treatment with ADSC-CM. Left panels show the adjusted relative % change of the 5 positive (green bars) and 2 negative (Orange bars) parameters, where the bar height represents the percentage change in the given parameter by reference to the population baseline mean. Right panels (in blue) show the mean derived Sinclair grade in baseline versus after treatment with ADSC-CM. Panels are organized by scalp region, including frontal (upper), temporal (middle), and occipital (lower) region.

Figure 1 Change in hair growth indicators, by scalp region, in patients with telogen effluvium after treatment with ADSC-CM. Left panels show the adjusted relative % change of the 5 positive (green bars) and 2 negative (Orange bars) parameters, where the bar height represents the percentage change in the given parameter by reference to the population baseline mean. Right panels (in blue) show the mean derived Sinclair grade in baseline versus after treatment with ADSC-CM. Panels are organized by scalp region, including frontal (upper), temporal (middle), and occipital (lower) region.

Table 2 Pre- and Post-Intervention Trichometry Findings by Scalp Region (Intrasubject Analysis)

Figure 2 Pre- and post ADSC-CM clinical photography of a 39-year-old female patient showing an aesthetic improvement of the midline and bitemporal areas. The figures have been used with written consent of the patient.

Figure 2 Pre- and post ADSC-CM clinical photography of a 39-year-old female patient showing an aesthetic improvement of the midline and bitemporal areas. The figures have been used with written consent of the patient.

Figure 3 Pre- and post ADSC-CM trichometry of a 39-year-old female patient with telogen effluvium.

Figure 3 Pre- and post ADSC-CM trichometry of a 39-year-old female patient with telogen effluvium.

Table 3 Favorable Response Rate by Trichometry Parameter and Extent of Change Among Responders

Table 4 Comparison of the Absolute Change in Trichometry Parameters Between Idiopathic and Secondary Telogen Effluvium After Treatment with ADSC-CM